IL15 and cancer: For example, Heczey et al. conducted a trial study to evaluate the autologous CAR-GD2-expressing IL-15 NKT cells (GINAKIT2) on the refractory/relapsed neuroblastoma cancer in three child patients by CD4+ CD62L+ cells (NCT03294954).